abstract MRI plays a central role in the assessment of pediatric musculoskeletal soft tissue tumors. Although these neoplasms may initially be evaluated on other modalities, such as sonography, MRI is essential for accurately determining the extent of disease. Traditionally, MRI has been performed with sequences that provide excellent anatomic detail, with T1-weighted, fluid-sensitive, and static postcontrast T1-weighted sequences. However, with the introduction of noncontrast sequences such as diffusion-weighted imaging and magnetic resonance spectroscopy to the arsenal of available MRI techniques, functional and metabolic features of a neoplasm can now be examined noninvasively. These more recent MRI methods offer information for lesion characterization, the assessment of treatment response, and the distinction of postoperative scar from recurrence. Dynamic contrast-enhanced perfusion imaging is another useful functional technique that can be acquired before conventional static postcontrast imaging, without requiring additional contrast material. This review presents recent advances in MRI methodology that enable a comprehensive clinical assessment of musculoskeletal tumors in the pediatric population. The roles and challenges of combining anatomic, functional, and metabolic MRI sequences will be discussed as they relate to newly discovered soft tissue tumors in children.
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A principal role for MRI in the evaluation of pediatric musculoskeletal tumors is the determination of extent of disease for appropriate preoperative planning. Diffusion-weighted imaging (DWI), dynamic contrast-enhanced perfusion imaging (DCE-MRI), and magnetic resonance spectroscopy (MRS) have expanded the role of MRI to include lesion characterization, treatment response, and the detection of postsurgical recurrence. In this review, conventional (anatomic sequences) and advanced (functional and metabolic sequences) imaging will be discussed, with an emphasis on how these sequences are used in the clinical setting of newly discovered (de novo) pediatric soft tissue tumors. The assessment of treatment response and postsurgical recurrence is beyond the scope of this article.
CHALLENGES IN THE PEDIATRIC PATIENT
Pediatric imaging presents unique challenges that are not encountered in the adult setting. The need for sedation in young children requires that a comprehensive protocol also be succinct. A complete tumor protocol that includes anatomic, functional, and metabolic sequences has been previously described. 1 The examination requires 60 minutes, with 15 minutes of this time allotted to MRS if desired (see Table 1 ).
Additional challenges encountered in pediatric patients include their small size with resultant decreased signal and inherently low scan resolution. Therefore, choosing a coil that closely matches the field of view being imaged is critical to extracting the maximum signal from pediatric patients. Three-dimensional volumetric imaging with isotropic resolution allows for high spatial resolution without gap imaging and reconstruction in other planes from only 1 acquisition; as such, an accurate lesion size can be obtained.
Understanding the advantages and disadvantages of each sequence in the tumor protocol (discussed below) allows the radiologist to choose specific sequences to best optimize the protocol in an effort to conserve time and tailor an examination to a particular clinical indication (Table 2) .
TUMOR PROTOCOL: ANATOMIC IMAGING

T1-Weighted Sequences
Pure spin-echo T1-weighted imaging is performed to take advantage of the differences in T1 relaxation properties between a tumor and the surrounding tissues. In fact, a nonenhanced spin-echo T1-weighted image has been established as the most important sequence for the assessment of marrow replacement or intraosseous extension of a neoplasm. 2 
Fluid-Sensitive Sequences
Although both short tau inversion recovery (STIR) and chemical fat suppression of T2-weighted sequences can produce fluid-sensitive images, STIR reportedly offers greater contrast resolution between fluid and the surrounding tissues. 3, 4 Recent developments in producing fluid-sensitive imaging include threedimensional sequences of isotropic resolution, such as the steady state gradient echo sequences; however, as yet, these sequences have not been specifically studied to determine if they provide optimal contrast between a tumor and other musculoskeletal structures.
Static Postcontrast T1-Weighted Sequences
The application of fat suppression to a T1-weighted postcontrast sequence provides improved contrast resolution for identifying areas that exhibit contrast enhancement. In addition, static postcontrast parameters may be combined with high spatial resolution (isotropic resolution) with the use of threedimensional gradient-echo sequences; the latter may be acquired in a single plane ∼3 to 5 minutes after contrast injection, then subsequently reformatted into multiple other planes. Subtraction images are also valuable and can be constructed by subtracting the unenhanced images from the contrast-enhanced images to further exploit the difference in contrast between an enhancing tumor and surrounding normal musculoskeletal tissues.
TUMOR PROTOCOL: FUNCTIONAL IMAGING DWI
Unlike anatomic sequences, DWI is a method of functional imaging. [5] [6] [7] [8] [9] [10] [11] [12] [13] DWI measures the Brownian motion of water at a microscopic level within the intra-and extracellular spaces. 5, 6 Water flows relatively freely in the extracellular space and demonstrates restricted diffusion in the intracellular space. 5 Therefore, cellular regions, such as tumors, show restricted diffusion and DWI can be used to gauge the degree of cellularity or cellular integrity.
Any sequence may be altered to be diffusion sensitive, although in clinical practice, T2-weighted sequences are most commonly used for this purpose. The magnitude of the sensitivity of the sequence to Brownian motion is described by the b-value and at least 2 (preferably .2) different b-values are used. The choice of exact b-value is likely not critical as long as a mixture of low and high b-values are used. 7, 8 In our practice, b-values of 50, 400, and 1000 s/mm2 are used but values of 0 and 1000 s/mm2 have also been discussed. 7, 8 DWI analysis can be qualitative or quantitative. For a qualitative analysis, the images are assessed visually for approximate loss of signal as diffusion weighting successively increases. For quantitative analysis, a region of interest (ROI) is drawn and the minimum, average, and maximum apparent diffusion coefficient (ADC) values may be recorded. Viable malignant tissue shows little loss of signal intensity on diffusion-weighted images obtained with successively heavier diffusion weighting, whereas benign tissues or malignant tissues that have undergone necrosis lose their signal intensity with progressively heavier diffusion weighting. There is no standard procedure for the size or placement of the ROI used to determine ADC values, a potential cause for interreader variability among studies. In our practice, an elliptical ROI is placed to encompass most of the lesion on multiple images, where the tumor appears to have the lowest signal on the ADC map.
Although DWI has many advantages, there are pitfalls as well: DWI has inherent low signal-to-noise and resolution (making it unreliable in small subcentimeter lesions) and is prone to susceptibility artifacts (producing false-positive regions of apparent restricted diffusion in areas containing or adjacent to blood products and air). As such, DWI is always interpreted in conjunction with anatomic sequences. It may, however, be particularly useful when intravenous contrast cannot be administered, 13 which is an additional advantage in the pediatric population.
Perfusion/DCE-MRI
DCE-MRI is typically performed with rapid, volumetric, gradient-echo sequences that cover a volume of interest repeatedly after the intravenous administration of a contrast agent. 14 Contrast material is usually injected intravenously at a rate of 2 to 5 mL/second, and imaging takes place with a temporal resolution of 3 to 10 seconds 15 carried out for as short as 2 minutes or as long as 5 to 7 minutes. The temporal resolution chosen for this pulse sequence depends on the need for spatial resolution and field-ofview coverage. In our practice, we perform a highly time-resolved magnetic resonance (MR) angiographic sequence, which uses a spiral trajectory that acquires k space from the center to the periphery, relying on partial k-space undersampling and increased sampling of the center of k space 
APPLICATIONS OF MRI FOR NEWLY DISCOVERED SOFT TISSUE MASSES
Soft tissue tumors are rare in childhood and adolescence. The most common benign mass is vascular (a hemangioma of infancy or a vascular malformation in later ages), whereas the most common malignancy is rhabdomyosarcoma. 32 The nonrhabdomyosarcoma soft tissue sarcomas include synovial sarcoma, malignant fibrous histiocytoma, fibrosarcoma, and malignant peripheral nerve sheath tumors (especially in neurofibromatosis type 1). 32 The role of various MR sequences for the detection, characterization, and determination of tumor extent in soft tissue masses will be discussed below. 33 Hemangiomas characteristically lack perilesional edema and arteriovenous shunting. Hence, when perilesional edema is identified, other neoplastic lesions should be excluded. 33 For masses that do not meet strict clinical criteria for benignity by the pediatrician or surgeon, the first-line study in children is typically an ultrasound, and cysts, hemangiomas, and fibrous pseudotumors (eg, fibromatosis colli) can often be characterized with ultrasound alone (Fig 1) .
Otherwise, primary soft tissue masses are a heterogeneous group with variable T1 and T2 relaxation properties and enhancement patterns (Fig 2) . The T1 and T2 signal characteristics represent variations within the tumor microenvironment related to hemorrhage, necrosis, mineralization, and myxoid content and generally do not indicate
FIGURE 2
Nine-year-old girl with right calf myxofibroma. A, Axial T1-weighted image (TR/TE 450/16) shows a right posterior calf subcutaneous mass (arrow) that is isointense and indistinguishable from adjacent skeletal muscle. B and C, Fluid-sensitive STIR (TR/TE 3600/53/180) (B) and static postcontrast fat-suppressed images (TR/TE 17.5/9.52) (C) are essential in lesion detection and characterization, identifying the posterior knee soft tissue mass (arrow) as a solid lesion rather than a cyst. D, The ADC map also shows the hypointense mass (arrow) with a minimum ADC value of 0. Lesions containing macroscopic fat (lipomatous masses) are characterized by their high T1 signal that is suppressed on fat-suppressed sequences. A lipoblastoma in an older child can be diagnosed due to its intrinsic macroscopic fatty composition and resultant high T1 signal; however, lipoblastomas in younger children may contain more myxoid elements, confounding the diagnosis. 35 The more important dilemma for characterizing lipomatous masses is deciding whether they are benign or malignant. Usually, lipoblastomas cannot be confidently distinguished from liposarcomas by imaging alone, although liposarcomas are extremely rare in children, comprising 3% of non-rhabdomyosarcoma sarcomas. 36 Intravenous contrast may be helpful in identifying enhancing nodular nonlipomatous regions in a tumor to identify malignancy. There is little information on the use of functional techniques in the assessment of lipomatous masses and a report of
FIGURE 3
Thirteen-year-old girl with desmoid of the chest. A, Coronal T2-weighted image (TR/TE 6292/56) shows a large right hemithoracic hyperintense mass (arrow). It is indistinguishable from a malignant lesion on anatomic imaging alone. B, Coronal image from a dynamic contrast-enhanced study (TR/TE 2.66/0.98) shows lack of early arterial enhancement (arrow) (a feature of benignity). C, Subtraction postcontrast T1-weighted image (TR/TE 4.24/1.74) shows minimal homogeneous enhancement (arrow), consistent with, but not specific for, benign disease (because malignant lesions are more commonly heterogeneous).
FIGURE 4
Seven-year-old girl with right calf alveolar rhadomyosarcoma. A, There is a right calf anterior compartment mass that is minimally hyperintense to skeletal muscle on T1-weighted image (TR/TE 688/16). B and C, The fluid-sensitive images (TR/TE 6292/56) (B) and static postcontrast images (TR/TE 4.24/1.74) (C) aid in the assessment of tumor extent. However, there is considerable overlap in the anatomic imaging features of this malignant lesion compared with the benign myxofibroma in Fig 1. D MRS showed its potential utility in confirming a benign etiology within a complex lipomatous mass. 37 Once cystic, lipomatous, and vascular lesions have been ruled out, it is estimated that the ability of MRI to accurately characterize lesions is low, often ,50%. [38] [39] [40] [41] Patterns of contrast enhancement in benign and malignant lesions overlap, 38 and with DCE-MRI malignant lesions typically demonstrate rapid early arterial enhancement and higher slopes of enhancement compared with benign lesions, 15, [17] [18] [19] but this pattern is not entirely specific (Fig 3) . Finally, MRS is an emerging technique that has recently been applied to the characterization of musculoskeletal tumors. At this time, the utility of MRS lies with its high negative predictive value. 1 If no appreciable choline-containing compounds are detectable in a tumor, it is likely to be benign (Fig 6) . And, as various quantitative methods are validated,
FIGURE 5
Nineteen-year-old young man with left thigh synovial sarcoma. A and B, Axial T1-weighted (TR/TE 961/9.9) (A) and T2-weighted fat suppressed (TR/TE 3600/71) (B) images show left lateral thigh intramuscular mass with internal heterogeneity (arrow). C, Static postcontrast fat-suppressed T1-weighted image (TR/TE 4.08/1.48) also shows heterogeneous internal enhancement (arrow). D and E, The functional images demonstrate restricted diffusion on the ADC map (arrow) as denoted by dark regions within the mass (TR/TE 7600/80) (D) as well as early arterial enhancement with neovascularity on the DCE-MR angiography (arrow) (TR/TE 2.83/1.08), MRI features of malignancy (E).
MRS may prove to yield additional specificity for lesion characterization. 37 
Determination of Extent
For soft tissue tumors, contrast material is routinely administered, although primarily for characterization purposes (to help distinguish cystic from solid soft tissue masses) rather than for defining the extent. T1-weighted and fluid-sensitive sequences provide adequate anatomic detail for defining the borders of the tumor, but perilesional enhancement after contrast administration is important in identifying tumor extension beyond the direct boundaries of a sarcoma. 
CONCLUSIONS
